Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Synbiotics in Human Health: Biology to Drug Delivery -

Synbiotics in Human Health: Biology to Drug Delivery

Kamal Dua (Herausgeber)

Buch | Hardcover
718 Seiten
2024 | 2024 ed.
Springer Verlag, Singapore
978-981-99-5574-9 (ISBN)
CHF 889,95 inkl. MwSt
  • Titel nicht im Sortiment
  • Artikel merken
This reference book discusses the role of synbiotics in a wide range of disease states, including cardiovascular, reproductive, metabolic, neurodegenerative, gastrointestinal, thrombotic, skin, and inflammatory disorders. It reviews the functions of probiotics in the diagnosis, prevention, or treatment of various disease states. The book further covers improving the targeting efficiency of synbiotics through advanced drug delivery systems such as nanoparticles, microparticles, liposomes, microemulsion, solid lipid nanoparticles, and nano lipid carriers. The chapter addresses the implications of oral and topical delivery of synbiotics in different diseases and presents the safety assessment of synbiotics and clinical trials associated with synbiotics containing drug delivery systems for the treatment of diseases. The book also explores the synergistic welfare of synbiotics nutraceuticals in various conditions such as chronic respiratory diseases, gut health, and neurological functions and examines the toxicological profile, and regulatory aspects of nutraceutical supplements. As such, this book is a valuable resource for academics, research and industry professionals working in Pharmaceutical Sciences, Food Biotechnology, Immunology, and Health Sciences.​

Dr. Kamal Dua is a Senior Lecturer in the Discipline of Pharmacy at the Graduate School of Health, University of Technology Sydney (UTS), Australia. He has research experience of over 12 years in the field of drug delivery systems targeting inflammatory diseases. Dr. Dua is also a Node Leader of Drug Delivery Research in the Centre for Inflammation at Centenary Institute/UTS, where the targets identified from the research projects are pursued to develop novel formulations as the first step towards translation into clinics. Dr. Dua researches in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another, helping the community to live longer and healthier. This is evidenced by his extensive publication record in reputed journals. Dr. Dua’s research interests focus on harnessing the pharmaceutical potential of modulating critical regulators such as Interleukins and microRNAs and developing new and effective drug delivery formulations for the management of chronic airway diseases. He has published more than 440 research articles in peer-reviewed international journals and authored or co-authored four books. He is an active member of many national and international professional societies.

Introduction to Synbiotics.- Role of Synbiotics on modulation of inflammation.- Role of synbiotics in inflammatory lung diseases.- Role of Synbiotics in Neurodegenerative Diseases.- Role of Synbiotics in Gastrointestinal Disorders.- Role of Synbiotics in Cardiovascular diseases.- ROLE OF SYNBIOTICS IN THROMBOTIC DISORDERS.- Role of Synbiotics in Reproductive disorders.- Role of Synbiotics in Metabolic Disorders.- SYNBIOTICS FOR THE PREVENTION AND TREATMENT OF SKIN DISORDERS.- Cellular and Molecular mechanisms involving synbiotics in various disease state.- Clinical Trial with Synbiotics in Various Disease State.- FUTURE PERSPECTIVE AND SAFETY ISSUES OF SYNBIOTICS IN DIFFERENT DISEASES.- Role of nutraceutical-based synbiotics in the biological homeostasis.- Synergistic welfare of synbiotic nutraceuticals on chronic respiratory diseases.- Synergistic welfare of symbiotic nutraceuticals on gut health.- Synergistic welfare of synbiotic nutraceuticals on neurological function.- SynergisticWelfare of Synbiotic Nutraceuticals on Reproductive Health.- Quality Control and Evaluation of Synbiotics Neutraceutical Product.- Toxicological profile of nutraceutical supplements.- TRANSLATIONAL RESEARCH & CLINICAL ADVANCEMENTS WITH NUTRACEUTICAL SUPPLEMENTS.- Regulatory Aspects and Bottlenecks for Nutraceuticals.- Future prospects and advancement in synbiotics containing Nutraceuticals.- Synbiotics and Drug Delivery: An introduction.- Emerging era of “biotics”: Prebiotics, probiotics and synbiotics.- Therapeutic potential of synbiotics in management of various disorders.- Synbiotics: Safety assessment and role in the prevention of diseases.- Synbiotics as a nutraceutical adjuvant: neuroprotective and neurorestorative effects.- Synbiotics: Complementary and synergistic approach against different carcinomas.- SYNBIOTICS IN ORAL DRUG DELIVERY.- Applications of synbiotics as cosmeceuticals.- Advanced drug delivery approaches containing synbiotics.- Ideal Synbiotics: Pharmacokinetic, pharmacodynamic and safety assessment.- Regulatory Aspects of Synbiotics-Based Delivery System.- An update on clinical trials on synbiotics.

Erscheinungsdatum
Zusatzinfo 150 Illustrations, color; 100 Illustrations, black and white; XXX, 718 p. 250 illus., 150 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Pflege
Medizin / Pharmazie Pharmazie
Technik Umwelttechnik / Biotechnologie
Wirtschaft
Schlagworte Drug Delivery • inflammation • Nutraceuticals • prebiotics • Probiotics • synbiotics
ISBN-10 981-99-5574-2 / 9819955742
ISBN-13 978-981-99-5574-9 / 9789819955749
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Deutsche Bearbeitung der englischsprachigen Version von Ric M. …

von Stefan Bleich; Dominik Dabbert; Stefan Kropp …

Buch | Softcover (2022)
Hogrefe Verlag
CHF 113,95